Ironwood Pharmaceuticals (IRWD) Intangibles (2016 - 2026)
Ironwood Pharmaceuticals (IRWD) posted Intangibles of $1.8 million for Q1 2026, down 9.9% sequentially from $2.0 million in Q4 2025, and down 30.85% YoY from $2.7 million in Q1 2025.
Ironwood Pharmaceuticals (IRWD) Intangibles (2016 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported Intangibles for 7 years, with the latest figure at $1.8 million in Q1 2026.
- Quarterly Intangibles fell 30.85% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (down 30.85% YoY) and the FY2025 annual result came in at $2.0 million, down 28.67% from the prior year.
- Intangibles declined to $1.8 million in Q1 2026 per IRWD's latest filing, from $2.0 million in the prior quarter.
- Over five years, Intangibles peaked at $4.1 million in Q2 2023 and troughed at $1.8 million in Q1 2026.
- A 4-year average of $3.0 million and a median of $3.0 million in 2024 frame the typical range for Intangibles.
- The sharpest annual moves came in 2024 and 2026: Intangibles fell 20.09% in 2024, then plunged 30.85% in 2026.
- Over 4 years, Intangibles stood at $3.7 million in 2023, then declined by 22.32% to $2.9 million in 2024, then dropped by 28.67% to $2.0 million in 2025, then dropped by 9.9% to $1.8 million in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $1.8 million, $2.0 million, and $2.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.12 Bn |
| 10 | Ironwood Pharmaceuticals | 679.81 Mn | 600.69 Mn | - | 1.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.63 Mn |
| Mar 31, 2026 | 1.84 Mn |
| Dec 31, 2025 | 2.04 Mn |
| Sep 30, 2025 | 2.25 Mn |
| Jun 30, 2025 | 2.45 Mn |
| Mar 31, 2025 | 2.66 Mn |
| Dec 31, 2024 | 2.86 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | 3.27 Mn |
| Mar 31, 2024 | 3.48 Mn |
| Dec 31, 2023 | 3.68 Mn |
| Sep 30, 2023 | 3.89 Mn |
| Jun 30, 2023 | 4.10 Mn |
| Jun 30, 2018 | 152.95 Mn |
| Mar 31, 2018 | 156.43 Mn |
| Dec 31, 2017 | 159.91 Mn |
| Sep 30, 2017 | 163.38 Mn |
| Jun 30, 2017 | 165.28 Mn |
| Mar 31, 2017 | 165.70 Mn |
| Dec 31, 2016 | 166.12 Mn |